Azeem Ansari

Azeem Ansari currently serves as the Global Head of CMC at Mallinckrodt Pharmaceuticals, focusing on technical and regulatory CMC for a diverse portfolio of branded pharmaceuticals including biologics and small molecules. Prior experience includes roles as Senior Director of Strategic External Development at Amicus Therapeutics, and Senior Program Adviser at PATH, where Azeem specialized in large and small molecule regulatory and technical CMC strategies as well as global vaccine CMC initiatives. Additional positions held include Director of Large Molecule CMC Development at Mylan, Deputy Director at Sanofi Pasteur, and Senior Scientist roles at Merck and Co. and Gene Therapy Systems. Azeem's academic credentials include a PhD in Molecular Virology from UCL, a BSc in Molecular Biology from the University of Glasgow, and completion of the Management Excellence Program at the Schulich School of Business.